Atom Investors’s Medifast MED Stock Holding History

Atom Investors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$659K	Buy	62,119 +1,044	+2%	+$12K	0.06%	484
2026 Q1	$622K	Buy	61,075 +40,273	+194%	+$434K	0.04%	436
2025 Q4	$222K	Buy	+20,802	New	+$249K	0.02%	490
2022 Q4	–	Sell	-13,474	Closed	-$1.46M	–	281
2022 Q3	$1.46M	Buy	+13,474	New	+$1.93M	0.51%	55
2019 Q2	–	Sell	-4,285	Closed	-$547K	–	537
2019 Q1	$547K	Sell	4,285 -9,806	-70%	-$1.24M	0.05%	296
2018 Q4	$1.76M	Buy	+14,091	New	+$2.41M	0.17%	120

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Atom Investors's MED Position: Q2 2026 in Review

Atom Investors increased its Medifast (MED) stake by 1.7% in Q2 2026, buying an estimated $12K and bringing the position to 62,119 shares worth $659K. The position accounts for 0.06% of the portfolio, ranked #484.

Atom Investors first reported a position in MED in Q4 2018 and has held it in 6 quarters since. The position peaked at $1.76M in Q4 2018. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Atom Investors held 62,119 shares of Medifast worth $659K as of Q2 2026.
Atom Investors bought 1,044 Medifast shares in Q2 2026, an estimated $12K.
Medifast made up 0.06% of Atom Investors's portfolio in Q2 2026, its #484 holding.
Atom Investors first reported a position in Medifast in Q4 2018 and has held it in 6 quarters since.
Atom Investors's Medifast position peaked at $1.76M in Q4 2018.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.